Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
RxSight ( (RXST) ) has issued an announcement.
On December 18, 2025, RxSight, Inc. announced executive leadership changes, naming Eric Weinberg as Chief Business Development Officer as he transitioned from his prior role as Chief Commercial Officer. On the same date, the company’s board appointed Scott Gaines as Chief Customer Officer, giving him responsibility for RxSight’s U.S. commercial organization and signaling a reorganization of its commercial leadership structure to support business development and customer-focused growth in its domestic market.
The most recent analyst rating on (RXST) stock is a Hold with a $13.00 price target. To see the full list of analyst forecasts on RxSight stock, see the RXST Stock Forecast page.
Spark’s Take on RXST Stock
According to Spark, TipRanks’ AI Analyst, RXST is a Neutral.
RxSight’s overall stock score reflects significant financial challenges, particularly in profitability and revenue growth, which weigh heavily on the score. Positive technical indicators provide some optimism, but the negative valuation metrics and absence of corporate events or dividend yield limit the stock’s attractiveness.
To see Spark’s full report on RXST stock, click here.
More about RxSight
Average Trading Volume: 780,498
Technical Sentiment Signal: Hold
Current Market Cap: $518.1M
Find detailed analytics on RXST stock on TipRanks’ Stock Analysis page.